Company intelligence / Profile preview

Orbicular Pharmaceutical Technologies

Hyderabad, Telangana, Indiaorbicular.co.in ↗
Ownership
Private
Employees
~300
Development stage
Other
01

Overview

The company has established a robust pipeline of niche specialty generics (including complex injectables, topicals, ophthalmics, parenterals, nasal/inhalation products, and peptide/iron colloid combination products) for global regulated and emerging markets. Products are mostly licensed out at late-stage development or registration to global partners for commercialization[4][1][3][10].

Modalities
Small moleculePeptidesBiologicDrug-device combinationIron colloidDevice
Industry
Biotech
02

Partnerships

Alembic

Beyond the preview

Go deeper on Orbicular Pharmaceutical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbicular Pharmaceutical Technologies.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call